Lineage Cell Therapeutics (LCTX) EBITDA Margin (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,108.00 |
| Dec 31, 2025 | 376.00 |
| Sep 30, 2025 | 61,252.00 |
| Jun 30, 2025 | -28,228.00 |
| Mar 31, 2025 | -25,492.00 |
| Dec 31, 2024 | -7,656.00 |
| Sep 30, 2024 | 31,508.00 |
| Jun 30, 2024 | 4,460.00 |
| Mar 31, 2024 | -15,659.00 |
| Dec 31, 2023 | 23,343.00 |
| Sep 30, 2023 | -38,234.00 |
| Jun 30, 2023 | 12,259.00 |
| Mar 31, 2023 | 6,831.00 |
| Dec 31, 2022 | -17,153.00 |
| Sep 30, 2022 | -8,216.00 |
| Jun 30, 2022 | 2,914.00 |
| Mar 31, 2022 | -6,565.00 |
| Dec 31, 2021 | 24,498.00 |
| Sep 30, 2021 | 108,136.00 |
| Jun 30, 2021 | 42,026.00 |